Long-term acceptance of primarily vascularized renal allografts in miniature swine. Systemic tolerance versus graft adaptation

Transplantation
P R GianelloD H Sachs

Abstract

We have previously demonstrated that tolerance to two-haplotype class I-mismatched renal allografts can be induced uniformly by a short course of cyclosporine. We report here that following transplant nephrectomy, 8 such long-term acceptor animals all accepted a second renal transplant MHC matched to the original donor without additional immunosuppression. These results indicate that the mechanism of tolerance to primarily vascularized renal allografts involves modification of the host's immune system by the first transplant. To assess the possibility that "graft adaptation" is also involved in the maintenance of tolerance, we retransplanted class I-disparate kidneys from tolerant animals into naive recipients MHC matched to the original recipient. Three of 4 such transplants were rejected acutely, while one animal demonstrated a markedly prolonged survival, but also eventually rejected. These results, therefore, demonstrate that: (1) graft adaptation is not required in order to maintain tolerance; (2) graft acceptance involves induction of systemic tolerance; and (3) graft adaptation may participate in kidney graft prolongation but is not sufficient to transfer tolerance to a secondary host.

Citations

Dec 3, 2003·Trends in Immunology·Christian LeGuern
Mar 11, 2015·Transplantation·Maria Lucia L MadariagaDavid H Sachs
Oct 10, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·C BaronC LeGuern
Jun 10, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Geetha ChalasaniFadi G Lakkis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.